Primary hyperparathyroidism

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 10, 2011, Pages

  Al Azem, Hafsah ^a   Aliya, Khan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ION; PARATHYROID HORMONE;

ADOLESCENT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CONSTIPATION; CREATININE CLEARANCE; DNA DETERMINATION; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; FATIGUE; HUMAN; HYPERCALCEMIA; LETHARGY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; THIRST;

EID: 79960196598     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090675     Document Type: Article

References (18)

1. Jacobs TP, Bilezikian JP. Rare causes of hypercalcemia. J Clin Endocrinol Metab 2005;90:6316-22.
2. Kronenberg HM, Shlomo M, Polonsky KS, et al. Williams textbook of endocrinology. 11th ed. Philadelphia (PA): Elsevier; 2008.
3. Shour R, Khan A. Approach to the patient with hypercalcemia: diagnostic principles. Diagnosis 2009;26:55-9.
4. Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on the bone. CMAJ 2000;163:184-7. (Pubitemid 30625659)
5. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:340-50.
6. Fuleihan GE. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 2002;17:N51-N56.
7. Silverberg SJ, Lewiecki EM, Mosekilde L, et al. Presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop. J Clin Endocrinol Metab 2009;94: 351-65.
8. Asymptomatic primary hyperparathyroidism: standards and guidelines for diagnosis and management in Canada: Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism position paper. Endocr Pract 2003;9:400-5.
9. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341:1249-55. (Pubitemid 29489739)
10. Performing and analyzing the forearm scan. In: QDR series user's guide. Bedford (MA): Hologic; 2005. p. 10-17.
11. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-71. (Pubitemid 33152604)
12. Bilezikian JP, Khan AA, Potts JT Jr. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism: guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. Clin Endocrinol Metab 2009;94:335-9.
13. Khan AA, Bilezikian JP, Potts JT Jr.; guest editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 2009;94:333-4.
14. Gotway MB, Leung JWT, Gooding GA, et al. Hyperfunctioning parathyroid tissue: spectrum of appearances on noninvasive imaging. AJR Am J Roentgenol 2002;179:495-502. (Pubitemid 34785661)
15. Udelsman R, Pasieka JL, Sturgeon C, et al. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:366-72.
16. Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Clin Endocrinol Metab 2009;94:373-81.
17. Grey A, Lucas J, Horne A, et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005;90:2122-6. (Pubitemid 40586249)
18. Khan AA, Bilezikian JP, Kung AW, et al. Alendronate in primary hyperparathyroidism: a double blind, randomized, placebo controlled trial. J Clin Endocrinol Metab 2004;89:3319-25.